• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3% 地夸磷索治疗干眼综合征患者后泪液量的变化:一项眼前节频域光学相干断层扫描研究

Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study.

作者信息

Lee Kwan Bok, Koh Kyung Min, Kwon Young A, Song Sang Wroul, Kim Byoung Yeop, Chung Jae Lim

机构信息

Department of Ophthalmology, Kim's Eye Hospital, Myung-Gok Eye Research Institute, Konyang University College of Medicine, Seoul, Korea.

出版信息

Korean J Ophthalmol. 2017 Aug;31(4):306-312. doi: 10.3341/kjo.2016.0056. Epub 2017 Jul 13.

DOI:10.3341/kjo.2016.0056
PMID:28752695
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5540985/
Abstract

PURPOSE

To evaluate changes in the tear meniscus area and tear meniscus height over time in patients with dry eye syndrome, using anterior segment spectral-domain optical coherence tomography after the instillation of 3% diquafosol ophthalmic solution.

METHODS

Sixty eyes from 30 patients with mild to moderate dry eye syndrome were included. Tear meniscus images acquired by anterior segment spectral-domain optical coherence tomography were analyzed using National Institutes of Health's image-analysis software (ImageJ 1.44p). Tear meniscus area and tear meniscus height were measured at baseline, 5 minutes, 10 minutes, and 30 minutes after instillation of a drop of diquafosol in one eye and normal saline in the other eye. Changes in ocular surface disease index score, tear film break-up time, corneal staining score by Oxford schema, and meibomian expressibility were also evaluated at baseline, and after 1 week and 1 month of a diquafosol daily regimen.

RESULTS

Sixty eyes from 30 subjects (mean age, 29.3 years; 8 men and 22 women) were included. In eyes receiving diquafosol, tear volume was increased at 5 and 10 minutes compared with baseline. It was also higher than saline instilled eyes at 5, 10, and 30 minutes. Changes in tear volume with respect to baseline were not statistically different after the use of diquafosol for 1 month. Ocular surface disease index score, tear film break-up time, and Oxford cornea stain score were significantly improved after 1 week and 1 month of daily diquafosol instillation, but meibomian expressibility did not change.

CONCLUSIONS

Topical diquafosol ophthalmic solution effectively increased tear volume for up to 30 minutes, compared to normal saline in patients with dry eye syndrome.

摘要

目的

使用3% 地夸磷索滴眼液滴眼后,通过眼前节谱域光学相干断层扫描技术评估干眼综合征患者泪液半月皱襞面积和高度随时间的变化。

方法

纳入30例轻至中度干眼综合征患者的60只眼。使用美国国立卫生研究院的图像分析软件(ImageJ 1.44p)分析通过眼前节谱域光学相干断层扫描获取的泪液半月皱襞图像。在一只眼滴入一滴地夸磷索,另一只眼滴入生理盐水后,于基线、5分钟、10分钟和30分钟测量泪液半月皱襞面积和高度。还在基线以及地夸磷索每日给药方案1周和1个月后,评估眼表疾病指数评分、泪膜破裂时间、牛津模式角膜染色评分和睑板腺可挤压性的变化。

结果

纳入30名受试者的60只眼(平均年龄29.3岁;8名男性和22名女性)。在接受地夸磷索的眼中,与基线相比,5分钟和10分钟时泪液量增加。在5分钟、10分钟和30分钟时,其泪液量也高于滴入生理盐水的眼。使用地夸磷索1个月后,泪液量相对于基线的变化无统计学差异。每日滴入地夸磷索1周和1个月后,眼表疾病指数评分、泪膜破裂时间和牛津角膜染色评分显著改善,但睑板腺可挤压性未改变。

结论

与生理盐水相比,局部使用地夸磷索滴眼液可有效增加干眼综合征患者的泪液量长达30分钟。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef3/5540985/00ab2618c1d6/kjo-31-306-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef3/5540985/2c9f81aea458/kjo-31-306-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef3/5540985/fb68a28052ad/kjo-31-306-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef3/5540985/0071b51b5e31/kjo-31-306-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef3/5540985/96e2da4aa6a5/kjo-31-306-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef3/5540985/48df69cd3c1f/kjo-31-306-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef3/5540985/00ab2618c1d6/kjo-31-306-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef3/5540985/2c9f81aea458/kjo-31-306-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef3/5540985/fb68a28052ad/kjo-31-306-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef3/5540985/0071b51b5e31/kjo-31-306-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef3/5540985/96e2da4aa6a5/kjo-31-306-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef3/5540985/48df69cd3c1f/kjo-31-306-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef3/5540985/00ab2618c1d6/kjo-31-306-g006.jpg

相似文献

1
Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study.3% 地夸磷索治疗干眼综合征患者后泪液量的变化:一项眼前节频域光学相干断层扫描研究
Korean J Ophthalmol. 2017 Aug;31(4):306-312. doi: 10.3341/kjo.2016.0056. Epub 2017 Jul 13.
2
Evaluation of Tear Meniscus Dynamics Using Anterior Segment Swept-Source Optical Coherence Tomography After Topical Solution Instillation for Dry Eye.局部应用滴眼液治疗干眼症后,使用眼前节扫频光学相干断层扫描技术评估泪膜半月板动力学
Cornea. 2016 May;35(5):654-8. doi: 10.1097/ICO.0000000000000807.
3
The Effect of Topical Diquafosol Tetrasodium 3% on Dry Eye After Cataract Surgery.3% topical diquafosol tetrasodium对白内障手术后干眼的影响
Curr Eye Res. 2016 Oct;41(10):1281-1285. doi: 10.3109/02713683.2015.1122813. Epub 2016 Apr 6.
4
Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.使用干眼相关生活质量评分问卷评估地夸磷索滴眼液对干眼患者生活质量的影响:对阅读和使用视觉显示终端患者的有效性。
Cornea. 2017 Aug;36(8):908-914. doi: 10.1097/ICO.0000000000001241.
5
Prominent Decrease of Tear Meniscus Height With Contact Lens Wear and Efficacy of Eye Drop Instillation.佩戴隐形眼镜导致泪液半月板高度显著降低以及滴眼剂滴注的效果
Eye Contact Lens. 2015 Sep;41(5):318-22. doi: 10.1097/ICL.0000000000000134.
6
The effects of 3% diquafosol sodium eye drop application on meibomian gland and ocular surface alterations in the Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice.3%双醋瑞因钠滴眼液对铜锌超氧化物歧化酶-1(Sod1)基因敲除小鼠睑板腺及眼表改变的影响。
Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):739-750. doi: 10.1007/s00417-018-3932-x. Epub 2018 Feb 27.
7
Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.用于治疗干眼症的地夸磷索钠滴眼液:泪液成分的临床评估和生化分析
Jpn J Ophthalmol. 2015 Nov;59(6):415-20. doi: 10.1007/s10384-015-0408-y. Epub 2015 Aug 27.
8
Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease.3% 地夸磷索滴眼液对泪膜破裂时间短型干眼患者的治疗效果
BMC Ophthalmol. 2018 Sep 5;18(1):237. doi: 10.1186/s12886-018-0910-3.
9
Facilitation of tear fluid secretion by 3% diquafosol ophthalmic solution in normal human eyes.3%双氯非那腙滴眼液促进正常人体泪液分泌。
Am J Ophthalmol. 2014 Jan;157(1):85-92.e1. doi: 10.1016/j.ajo.2013.09.009. Epub 2013 Nov 5.
10
Influence of Ophthalmic Solutions on Tear Components.眼科溶液对泪液成分的影响。
Cornea. 2016 Nov;35 Suppl 1:S71-S77. doi: 10.1097/ICO.0000000000000996.

引用本文的文献

1
Evaluation of effects of 3% diquafosol ophthalmic solution on preocular tear film stability after trabeculectomy.评价 3%双氯非腙滴眼液对小梁切除术后眼表泪膜稳定性的影响。
Int Ophthalmol. 2023 Jun;43(6):1903-1910. doi: 10.1007/s10792-022-02589-8. Epub 2022 Nov 21.
2
Short Tear Breakup Time Could Exacerbate the Progression of Presbyopia in Women.短的泪膜破裂时间可能会加剧女性远视的进展。
Biomed Res Int. 2022 Jan 28;2022:8159669. doi: 10.1155/2022/8159669. eCollection 2022.
3
Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study.

本文引用的文献

1
Tear meniscus dimensions in tear dysfunction and their correlation with clinical parameters.泪膜功能障碍中的泪液半月板尺寸及其与临床参数的相关性。
Am J Ophthalmol. 2014 Feb;157(2):301-310.e1. doi: 10.1016/j.ajo.2013.09.024. Epub 2013 Sep 28.
2
Facilitation of tear fluid secretion by 3% diquafosol ophthalmic solution in normal human eyes.3%双氯非那腙滴眼液促进正常人体泪液分泌。
Am J Ophthalmol. 2014 Jan;157(1):85-92.e1. doi: 10.1016/j.ajo.2013.09.009. Epub 2013 Nov 5.
3
Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for Meibomian gland dysfunction.
滴眼后干燥综合征患者的泪膜脂质层增加:一项随机临床研究。
Sci Rep. 2019 Jun 24;9(1):9091. doi: 10.1038/s41598-019-45475-7.
评估泪膜脂质层厚度作为睑板腺功能障碍的诊断工具。
Cornea. 2013 Dec;32(12):1549-53. doi: 10.1097/ICO.0b013e3182a7f3e1.
4
Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye.地夸磷索钠滴眼液治疗水样液缺乏性干眼的长期疗效。
Jpn J Ophthalmol. 2013 Sep;57(5):440-6. doi: 10.1007/s10384-013-0251-y. Epub 2013 Jun 6.
5
Tear meniscus evaluation by anterior segment swept-source optical coherence tomography.眼前节扫频源光学相干断层扫描评估泪膜半月板。
Am J Ophthalmol. 2013 Apr;155(4):620-624, 624.e1-2. doi: 10.1016/j.ajo.2012.11.009. Epub 2013 Jan 11.
6
Visante optical coherence tomography and tear function test evaluation of cholinergic treatment response in patients with sjögren syndrome.使用 Visante 光学相干断层扫描仪和泪液功能测试评估干燥综合征患者胆碱能治疗反应。
Cornea. 2013 May;32(5):653-7. doi: 10.1097/ICO.0b013e318261eb4a.
7
The diagnostic significance of Fourier-domain optical coherence tomography in Sjögren syndrome, aqueous tear deficiency and lipid tear deficiency patients.傅里叶域光学相干断层扫描在干燥综合征、水样液缺乏和脂质泪液缺乏患者中的诊断意义。
Acta Ophthalmol. 2012 Aug;90(5):e359-66. doi: 10.1111/j.1755-3768.2012.02413.x. Epub 2012 May 8.
8
Correlation between optical coherence tomography-derived assessments of lower tear meniscus parameters and clinical features of dry eye disease.基于光学相干断层扫描的泪河参数评估与干眼临床特征的相关性研究。
Cornea. 2012 Jun;31(6):680-5. doi: 10.1097/ICO.0b013e3182261577.
9
Application of visante optical coherence tomography tear meniscus height measurement in the diagnosis of dry eye disease.应用 Visante 光学相干断层扫描泪膜半月板高度测量诊断干眼。
Ophthalmology. 2010 Oct;117(10):1923-9. doi: 10.1016/j.ophtha.2010.01.057. Epub 2010 Jun 3.
10
Influence of the blink interval on tear meniscus height in soft contact lens and nonlens wearers.眨眼间隔对软性隐形眼镜和非隐形眼镜佩戴者泪膜弯月高的影响。
Eye Contact Lens. 2010 May;36(3):156-63. doi: 10.1097/ICL.0b013e3181dae228.